NEW YORK – A team from the UK and the Netherlands has identified recurrent somatic mutations in gut samples that appear to be linked to non-neoplastic cases of inflammatory bowel disease (IBD) that do not progress to cancer.
"Our study revealed that somatic changes in the DNA sequence of the cells that line our gut may contribute to the development of IBD," co-senior author Carl Anderson, a researcher at the Wellcome Trust Sanger Institute, said in a statement.